Enhanced delivery of topically-applied formulations following skin pre-treatment with a hand-applied, plastic microneedle array

Current Drug Delivery

Volumn 8, Issue 5, 2011, Pages 557-565

  Duan, Dan ^a   Moeckly, Craig ^a   Gysber, Jerry ^a   Novak, Chris ^a   Prochnow, Gayatri ^a   Siebenaler, Kris ^a   Albers, Leila ^a   Hansen, Kris ^a  

^a 3M COMPANY   (United States)

Author keywords

Dermis; Epidermis; Lidocaine; Microneedle; Stratum corneum penetration; Transdermal

Indexed keywords

DERMATOLOGICAL AGENT; LIDOCAINE; METHYLPREDNISOLONE SODIUM SUCCINATE; PLASTIC; POLYMER; TOPICAL AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DERMIS; DRUG DELIVERY SYSTEM; DRUG FORMULATION; EPIDERMIS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; MASS SPECTROMETRY; NEEDLE; NONHUMAN; PRIORITY JOURNAL; SKIN PENETRATION; STRATUM CORNEUM; SURFACE PROPERTY; SWINE;

ADMINISTRATION, TOPICAL; ANIMALS; FEMALE; LIDOCAINE; NEEDLES; SKIN; SWINE;

EID: 80051729786     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/156720111796642318     Document Type: Article

References (29)

1. Marieb, E.N.; Hoehn, K. Human Anatomy & Physiology. 8th ed.; Benjamin Cummings: San Francisco, 2010.
2. Gill, H. S.; Prausnitz, M. R. Coated microneedles for transdermal delivery. J. Control. Reease.,2007, 117 (2), 227-237.
3. Li, X.; Zhao, R.; Qin, Z.; Zhang, J.; Zhai, S.; Qiu, Y.; Gao, Y.; Xu, B.; Thomas, S. H. Microneedle pretreatment improves efficacy of cutaneous topical anesthesia. Am. J. Emer. Med.,2010, 28 (2), 130-134.
4. Glenn, G. M.; Villar, C. P.; Flyer, D. C.; Bourgeois, A. L.; McKenzie, R.; Lavker, R. M.; Frech, S. A. Safety and immunogenicity of an enterotoxigenic escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum. Infect. Immun.,2007, 75, 2163-2170.
5. Garg, S.; Hoelscher, M.; Belser, J.A.; Wang, C.; Jayashankar, L.; Guo, Z.; Durland, R.H.; Katz, J.M.; Sambhara, S. Needle-free skin patch delivery of a vaccine for a potentially pandemic influenza virus provides protection against lethal challenge in mice. Clin. Vacc. Immun.,2007, 14 (7), 926-928.
6. Sintov, A. C.; Krymberk, I.; Daniel, D.; Hannan, T.; Sohn, Z.E.; Levin, G. Radiofrequency-driven skin microchanneling as a new way for electrically assisted transdermal delivery of hydrophilic drugs. J. Control. Release.,2003, 89 (2), 311-320.
7. Mikolajewska, P.; Donnelly, R.; Garland, M.; Morrow, D.; Singh, T.; Iani, V.; Moan, J.; Juzeniene, A. Microneedle pre-treatment of human skin improves 5-aminolevulininc acid (ala)- and 5-aminolevulinic acid methyl ester (mal)-induced ppix production for topical photodynamic therapy without increase in pain or erythema. Pharm. Res.,2010, 27 (10), 2213-2220.
8. Burton, S.; Ng, C.-Y.; Simmers, R.; Moeckly, C.; Brandwein, D.; Gilbert, T.; Johnson, N.; Brown, K.; Alston, T.; Prochnow, G.; Siebenaler, K.; Hansen, K. Rapid intradermal delivery of liquid formulations using a hollow microstructured array. Pharm. Res., 2011, 28(1), 31-40.
9. Daddona, P.; Matriano, J.; Mandema, J.; Maa, Y.-F. Parathyroid hormone (1-34)-coated microneedle patch system: clinical pharmacokinetics and pharmacodynamics for treatment of osteoporosis. Pharm. Res, 2011, 28(1), 159-165.
10. Sullivan, S.; Dimitrios, K.G.; del Pilar Martin, M.; Joeng Woo, L.; Vladimir, Z.; Seong-O, C.; Richard, C.;, Ioanna, S.; Mark, P. Dissolving polymer Microneedle Patchesfor Influenza Vaccination. Nat. Med.,2010, 16,915-920.
11. Compans, R. W.; Orenstein, W. A.; Prausnitz, M. R.; Mikszta, J. A.; Cormier, M.; Andrianov, A. K. In: Vaccines for Pandemic Influenza, Springer: Berlin Heidelberg, 2009; Vol. 333, pp.369-393.
12. Badran, M. M.; Kuntsche, J.; Fahr, A. Skin penetration enhancement by a microneedle device (Dermaroller®) in vitro: Dependency on needle size and applied formulation. Eur. J. Pharm. Sci.,2009, 36 (4-5), 511-523.
13. Milewski, M.; Brogden, N. K.; Stinchcomb, A. L. Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin. J. Drug Targets,2010, 7 (5), 617-629.
14. Milewski, M.; Stinchcomb, A. Vehicle composition influence on the microneedle-enhanced transdermal flux of naltrexone hydrochloride. Pharm. Res.,2011, 28 (1), 124-134.
15. Levin, G.; Gershonowitz, A.; Sacks, H.; Stern, M.; Sherman, A.; Rudaev, S.; Zivin, I.; Phillip, M. Transdermal delivery of human growth hormone through rf-microchannels. Pharm. Res.,2005, 22 (4), 550-555.
16. Litscher, G.; Wang, L.; Huber, E.; Nilsson, G. Changed skin blood perfusion in the fingertip following acupuncture needle introduction as evaluated by laser doppler perfusion imaging. Lasers Med. Sci.,2002, 17 (1), 19-25.
17. Fabbrocini, G.; Fardella, N.; Monfrecola, A.; Proietti, I.; Innocenzi, D., Acne scarring treatment using skin needling. Clin. Exper. Derm.,2009, 34 (8), 874-879.
18. Majid, I., Microneedling therapy in atrophic facial scars: an objective assessment. J. Cut. Aesth. Surg.,2009, 2 (1), 26-30.
19. Doddaballapur, S., Microneedling with dermaroller. J. Cut. Aesth. Surg.,2009, 2 (2), 110-111.
20. Cho, S. B., Lee, S.J.; Kang, J.M.; Kim, Y.K.; Kim, T.Y.; Kim, D.H. The treatment of burn scar-induced contracture with the pinhole method and collagen induction therapy: a case report. J. Eur. Acad. Derm. Vener.,2007, 22 (4), 513-514.
21. Bal, S.; Kruithof, A. C.; Liebl, H.; Tomerius, M.; Bouwstra, J.; Lademann, J.; Meinke, M. In vivo visualization of microneedle conduits in human skin using laser scanning microscopy. Laser Phys. Lett.,2010, 7 (3), 242-246.
22. Kalluri, H.; Banga, A., Formation and closure of microchannels in skin following microporation. Pharm. Res. 2011, 28 (1), 82-94.
23. Hansen, K. J. In: High Volume Intradermal Drug Delivery- Potential for Improved Therapeutic Profile for Biologics, 5th Biologic Therapeutics Research and Development, GTC: San Francisco, CA, 2010.
24. Aust, M. C.; Reimers, K.; Repenning, C.; Stahl, F.; Jahn, S.; Guggenheim, M.; Schwaiger, N.; Gohritz, A.; Vogt, P. M. Percutaneous collagen induction: minimally invasive skin rejuvenation without risk of hyperpigmentation-fact or fiction? Plas. Recon. Surg.,2008, 122 (5), 1553-1563.
25. Wu, Y. Q.; Zhang, S.; Qin, G.; Gao, Y. Microneedle-based drug delivery: studies on delivery paramters and biocompatability. Bio.Micro.,2008, 10, 601-610.
26. Daddona, P.; Matriano, J.; Mandema, J.; Maa, Y.-F. Parathyroid hormone (1-34)-coated microneedle patch system: clinical pharmacokinetics and pharmacodynamics for treatment of osteoporosis. Pharm. Res.,2011, 28 (1), 159-165.
27. Gupta, J; Eric, F.; Mark, P. Minimally invasive insulin delivery in subjects with type 1 diabetes using hollow microneedles. Diab. Tech. Thera.,2009, 11 (6), 329-337.
28. Laurent, P. E.; Bonnet, S.; Alchas, P.; Regolini, P.; Mikszta, J. A.; Pettis, R.; Harvey, N. G. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine, 2007, 25 (52), 8833-8842.
29. Donnelly, R. F.; Morrow, D. I. J.; McCarron, P. A.; Woolfson, A. D.; Morrissey, A.; Juzenas, P.; Juzeniene, A.; Iani, V.; McCarthy, H. O.; Moan, J. Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: Potential for enhanced topical photodynamic therapy. J. Control. Release, 2008, 129 (3), 154-162.